Updates in management of Gynecological cancer

It gives me immense pleasure to have the honour of this correspondence.

Things change, when we choose to change them. Waiting for things to happen would not beget any change. And I would like to present you an opportunity to be a part of a radical change that would bring a new lease of life to many who are yet not aware that they are headed down the wrong corridor unknowingly, unsuspectingly.

I would like to draw your attention to a grave cause which has been plaguing India and many other Low and Middle Income Countries – Cancer. In fact, there is gradual yet consistent increase in the incidence of cancer the world over. The present cancer burden is quite alarming globally and India. What is more alarming is that this figure is going to increase 50% by the year 2020 as predicted by World Health Organization.

Gynecologic oncology focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. In the United States, 82,000 women are diagnosed with gynecologic cancer annually. In 2013, an estimated 91,730 were diagnosed. The comprehensive global cancer statistics from the International Agency for Research on Cancer indicate that gynecological cancers accounted for 19% of the 5.1 million estimated new cancer cases, 2.9 million cancer deaths and 13 million 5-year prevalent cancer cases among women in the world in 2002.Cervical cancer accounted for 493 000 new cases and 273 000 deaths; uterine body cancer for 199 000 new cases and 50 000 deaths; ovarian cancer for 204 000 new cases and 125 000 deaths; cancers of the vagina, vulva and choriocarcinoma together constituted 45 900 cases. More than 80% of the cervical cancer cases occurred in developing countries and two-thirds of corpus uteri cases occurred in the developed world. Political will and advocacy to invest in healthcare infrastructure and human resources to improve service delivery and accessibility are vital to reduce the current burden in low- and medium-resource countries.

NCI-India has been envisaged by the Government of India as an Institute of National importance which will look after cancer research and formulation of modern therapy for cancer patients in India. This state of the art translational cancer research centre will have more than 700 beds and more than 3000 employees working in a campus of 50 acres. The NCI will start functioning in July, 2018. We have started collaboration with national and international institutes of excellence for promoting translational and clinical research in different India centric cancers. We have also started educational series on updates in management of different cancers as an initiative of NCI, India. In order to take this initiative forward, we plan to organize “ Updates in management of Gynecological cancer ” in National Cancer Institute, India, All India Institute of Medical Sciences, New Delhi scheduled on 4th – 6th August, 2017.

We solicit your support for the conference and look forward to see you.


Prof G K Rath
Head NCI & Chief Dr B R A IRCH

Dr. Abhishek Shankar

Assistant Professor, Preventive Oncology, DRBRAIRCH, All India Institute of Medical Sciences, New Delhi

Dr. Ajeet Gandhi

Assistant Professor Radiation Oncology , RML Lucknow

Dr. Atul Batra

Assistant Professor, Medical Oncology, All India Institute of Medical Sciences, New Delhi

Dr. B C Das

Chairman & H. G. Khorana Chair Professor AIMMSCR DEAN, Health & Allied Sciences Amity University Uttar Pradesh Campus, Noida

Dr. Bhawna Sirohi

Medical Oncologist Queen Mary’s Hospital, London

Dr. Bivas Biswas

Medical Oncologist, Tata medical Center, Kolkata

Dr. Chandra Prakash Prasad

Assistant Professor, All India Institute of Medical Sciences, New Delhi

Dr. D N Sharma

Professor, Dept. of Radiation Oncology, AIIMS, New Delhi

Dr. G K Rath

Head NCI-India, Chief Dr B R A IRCH AIIMS New Delhi

Dr. Jagadesan P

Associate Professor, Department of Radiation Oncology, Regional Cancer Centre, JIPMER,Puducherry

Dr. N K Shukla

Professor Head, surgical Oncology,DRBRAIRCH, AIIMS, Delhi

Dr. Preetha Rajaraman

South Asia Program Director, Center for Global Health, National Cancer Institute

Dr. Priya Tiwari

Associate Consultant , Medical Oncology, Fortis Memorial Research Institute, New Delhi

Dr. Raja Pramanik

Assistant Professor, Medical Oncology, AIIMS

Dr. Ritesh Kumar

Assistant Professor , Department of Radiation Oncology, AIIMS, New Delhi

Dr. Ruchir Bhandari

Consultant Radiation Oncologist, Manipal Hospitals, Jaipur

Dr. Sachidanand Jee Bharti

Associate Professor of Oncoanaesthesiology & Palliative Medicine, AIIMS , New Delhi

Dr. Seema Mishra

Professor, Oncoanaesthesia & Palliative Medicine, DRBRAIRCH, AIIMS, Delhi

Dr. Subhas Pandit

Consultant Radiation Oncologist , Kathmandu Cancer Center , Nepal

Dr. Supriya Mallick

Senior Research Associate, DRBRAIRCH, All India Institute of Medical Sciences, Delhi

Dr. Sushma Bhatnagar

Professor & Head, Radiotherapy Department, Regional Cancer Centre, Rohtak

Dr. Tejinder Kataria

Chairperson, Radiation Oncology at Medanta- The Medicity Hospital, Gurgaon

Dr. Vatsla Dadhwal

Professor, Obstetrics & Gynaecology,AIIMS, New Delhi

Dr. Vivek Kaushal

Professor & Head, Radiotherapy Department, Regional Cancer Centre, Rohtak


Session I: Prevention, Screening in Gynecological Cancer


  • Dr. N. K Shukla
  • Dr. Tanvir Kaur

  • Time Topic Speaker
    09.00-09.15 Epidemiology of Gynecological Cancer Dr. G K Rath
    09.15-09.30 Prevention of Gynecological Cancer: Evidence and Possibility in India Dr. Bhawna Sirohi
    09.30-09.45 HPV vaccination: Target Population and Future Perspective Dr. B.C. Das
    09.45-10.00 Screening methods in Gynae Cancers: What is the optimum Dr. Preetha Rajaraman
    10.00-10.15 Familial and Hereditary factors in Gynecological Cancer Dr. Abhishek Shankar
10:15-10:45 TEA BREAK

Session II: Imaging & Diagnosis in Gynecological Cancer


  • Dr.Pratima Mittal
  • Dr. Sudha Salahan

  • Time Topic Speaker
    10.45-11.00 Imaging in Gynecological Cancer Dr. Harsh Mahajan
    11.00-11.15 Diagnosis and Staging of Gynecological Cancer Dr. Deepak Abrol
    11.15-11.30 Role of PET –CT in primary and recurrent Gynecological Cancer Dr. Punit Sharma
    11.30-11.45 SLNB vs LND for Gynecological Cancer Dr. Rupinder Sekhon
    11.45-12.00 Challenges for pathologist in Gynecological Cancer Dr. Sandeep Mathur

Session III: Management of Early Cervical Cancer


  • Dr. U P Sahi
  • Dr. Alka Kriplani

  • Time Topic Speaker
    12.00-12.15 Surgical approach in early cervical cancer Dr. Sunesh Kumar
    12.15-12.30 Cervical Cancer in Pregnancy: A surgeons perspective Dr. Vatsla Dadhwal
    12.30-12.45 Role of radiation in early cervical cancer Dr. V Kannan
    12.45-13.00 Optimal Chemotherapy for Early cervical Cancer Dr. Indranil Ghosh
    13.00-13.15 Evolution of ICRT for cervical cancer Dr. Tejinder Kataria
13.15-14.15 LUNCH BREAK

Session IV: Management of Locally Advanced Cervical Cancer


  • Dr. Anjali Tempe
  • Dr. Dilip Parida
  • Dr. Vivek Kaushal

  • Time Topic Speaker
    14.15-14.30 Optimal treatment for Locally Advanced Cervical Cancer Dr. S K Srivastava
    14.30-14.45 Emerging Strategies in the treatment of advanced cervical cancer: where does Bevacizumab fit in? Dr. Atul Batra
    14.45-15.00 Interstitial brachytherapy in Locally Advanced Cervical Cancer Dr. D N Sharma
    15.00-15.15 What is the role of surgery in management of recurrent cervical cancer Dr. Seema Singhal
    15.15-15.30 Is there a role of radiation in management of recurrent cervical cancer Dr. Ajeet K. Gandhi
    15.30-15.45 Recurrent and metastatic cervical cancer- systemic treatment Dr. Bivas Biswas
    15.45-16.00 Bone health and QOL in patients of cervical cancer Dr. Sachidanand Jee Bharti
16.00-16.30 TEA BREAK

Session V: Management of Endometrial Cancer


  • Dr. AK Anand
  • Dr. Mamta Gupta

  • Time Topic Speaker
    9.00-9.15 Surgical strategies in endometrial cancer- lymph-node dissection, laparoscopic Dr. Rama Joshi
    9.15-9.30 Is Lymph node dissection in Endometrial cancer necessary Dr. K Keditsu
    9.30-9.45 Role of adjuvant radiotherapy in early intermediate risk endometrial cancer Dr. Supriya Mallick
    9.45-10.00 Adjuvant systemic treatment in high risk endometrial cancer Dr. Ahitagni Biswas
    10.00-10.15 Brachytherapy in Endometrial Cancer Dr. Subhas Pandit
    10.15-10.30 Systemic treatment of metastatic / recurrent disease Dr. Priya Tiwari
10.30-11.00 TEA BREAK

Session VI: Management of Ovarian Cancer


  • Dr. PK Julka
  • Dr. Sangita Ajmani

  • Time Topic Speaker
    11.00-11.15 Surgery in Ovarian Cancer what is the update Dr. Asima Mukhopadhyay
    11.15-11.30 Chemotherapy in ovarian cancer : Adjuvant or NACT Dr. Raja Pramanik
    11.30-11.45 Optimising the treatment outcomes in Ovarian Cancer: Role of Bevacizumab Dr. Manish Singhal
    11.45-12.00 Secondary debulking: what is optimum Dr. Sabhyata Gupta
    12.00-12.15 Molecular and targeted therapy in ovarian cancers Dr. Prabhat Malik
    12.15-12.30 Evolving treatment approach in Ovarian Cancer (HIPEC/PIPEC) Dr. M D Ray
    12.30-12.45 Radiation in ovarian Cancer: Is there an opportunity Dr. Saikat Das

Session VII: Management of Vulva/ Vaginal Cancer


  • Dr. Nutan Agarwal
  • Dr. Pushpa Singh

  • Time Topic Speaker
    13.45-14.00 Optimal Surgery in vulvar/vaginal cancers Dr. Satinder Kaur
    14.00-14.15 Interstitial brachytherapy in vulva/vaginal cancer Dr. Jagadesan P
    14.15-14.30 Adjuvant radiotherapy in vulvar cancers – Indications and techniques Dr. Ritesh Kumar
    14.30-14.45 Systemic therapy in Vulvar cancer Dr. Dipanjan Panda

Session VIII: Association of Breast and Gynae Cancers


  • Dr. Rajesh Vashistha
  • Dr. VK Kadam

  • Time Topic Speaker
    14.45-15.00 Breast and Ovarian Cancer Syndrome Dr. Munish Gairola
    15.00-15.15 HRT as risk of Breast and Gynae Cancers Dr. Kanika Gupta
    15.15-15.30 Approach to case of Krukenberg tumor secondary to Breast Cancer Dr. Saritha Shamsunder
    15.30-15.45 Approach to breast cancer patients on Tamoxifen Dr. Sachin Khurana
    15.45-16.00 Follow up protocol for Breast/Gynecological Cancer Dr. Renu Madan
    16.00-16.15 Adjuvant management of uterine sarcomas Dr. Ruchir Bhandari
    16.15-16.30 Challenges in palliative care for gynecological Cancer Dr. Seema Mishra

    Session Co-ordinators:

  • Dr.Prashanth G
  • Dr.Carthikeyan S M
  • Dr.Yousra Izzuddeen
  • Dr.Srikanth Anne
16.30 -17.00 QUIZ 17.00 onwards VALEDICTORY FUNCTION

Foyer, JLN Auditorium

Welcome Address

  • Dr. G.K. Rath


  • Dr. D N Sharma
  • Dr. Haresh KP
  • Dr. Subhash Gupta
S.No Topic Speaker
1 Radiological Anatomy Dr Ritesh Kumar
2 Simulation Protocols Dr Ajeet Gandhi
3 OAR Delineation Dr Shikha Goyal

Tea Break


  • Dr. D N Sharma
  • Dr. Haresh KP
  • Dr. Subhash Gupta
S.No Topic Speaker
1 Nodal volume delineation in GYN malignancies Dr Ajeet Gandhi
2 Primary Target volume delineation in Cervical Cancer Dr Ritesh Kumar
3 Target Volume delineation in Image Based Brachy in Cervix Dr Ajeet Gandhi
4 Brachytherapy for Challenging cases Dr D N Sharma



  • Dr. D N Sharma
  • Dr. Haresh KP
  • Dr. Subhash Gupta
S.No Topic Speaker
1 Target volume delineation in postoperative cases Dr Subhas Pandit
2 Target Volume delineation in Carcinoma Vulva Dr Shikha Goyal

Interaction with Participants


  • Dr. D N Sharma


  • Dr. Ritesh Kumar
  • Dr. Shikha Goyal
  • Dr. Ajeet Gandhi
  • Dr. Subhas Pandit


  • Dr. Wineeta Melgandi
  • Dr. Ravi Kanodia

Dr. Ramalingaswamy Board Room, AIIMS, New Delhi

Video Session 1: Surgery for Cancer Cervix

S.No Topic Speaker
1 Laparoscopic Approach Dr. Alka Kriplani
2 Open surgery Dr Sunesh Kumar
3 Radical Vaginal Hysterectomy Dr. Juhi Bharti


  • Dr. Abha Singh
  • Dr. Sunesh Kumar

Video Session 2: Surgery for Endometrial cancer

S.No Topic Speaker
1 Open surgery Dr. Jyoti Meena

Video Session 3: Surgery for Ca Ovary

S.No Topic Speaker
1 Primary Debulking Surgery Dr.Deepika Gupta
2 Surgery for a Young Patient Dr.Jayshree
Dr. Sunesh Kumar
3 HIPEC Dr. M D Ray


Video Session 4: Surgery for Vulval Cancer

S.No Topic Speaker
1 Radical Vulvectony Dr.Seema Singhal
2 Sentinal LN Biopsy Dr.Jyoti Meena


  • Dr. Deepika Gupta
  • Dr.Jayashree Natarajan

Dept. of Biochemistry, AIIMS, New Delhi

Basics in Translational Oncology

  • Dr Chandra Prakash Prasad

Instrumentation in Molecular Oncology

  • Dr Debraj Singh Thoudam

PCR and its variants in diagnosis and prognosis of Gynaecological Cancers

  • Dr Subhradip Karmakar


In vitro tissue culture as a model System in gynaecological cancers.

  • Dr Mayank Singh

Studying protein expression and molecular events in gynaecological cancers.

  • Dr Ashok Sharma

Seminar Room, 1st Floor, Dr. BRAIRCH, AIIMS, New Delhi

Basic of palliative care

  • Dr Sushma Bhatnagar

Palliative care need in Gynecological cancers

  • Dr Sachidanand Jee Bharti

Cancer Pain management

  • Dr Vinod Kumar


Symptom management in Gynaecological Malignancies

S.No Topic Speaker
1 Bowel obstruction, Recurrent Ascitis, Nausea & Vomiting, Constipation Dr Nishkarsh Gupta
2 Vaginal Bleeding, Obstructive Uropathy, Lymphedema, DVT Dr.Rakesh Garg
3 End of life care and Ethical issues Dr Seema Mishra

Workshop Station

  • Medications
  • Interventional Pain Management
  • Stoma & Wound Care
  • Role of Physiotherapy

Quiz Master’s

  • Dr. Prashanth G
  • Dr. Carthikeyan S M
  • Dr. Yousra Izzuddeen
  • Dr. Srikanth Anne

Quiz prizes

  • Ist Prize 30000
  • 2nd Prize 20000
  • 3rd Prize: 10000
Each team: 3 members (One from each radiation oncology/Medical Oncology/Surgical Oncology )

Top 5 teams selection based on multiple choice questions (30 mins)

  • 20 Multiple choice questions will be asked. To answer these MCQ’s 15 mins will be allotted
  • Every correct answer shall be given 2 points and wrong answer shall have a negative marking of 1 point
  • If multiple teams tie, selection will be based on order of registration for quiz.

Round 1 : Audio visual round (15-20 mins)

  • Direct answer: 20 Points
  • Wrong answer : - 10 Points
  • On passing, first on buzzer gets chance.
  • Correct answer: 10 Points
  • Wrong answer: -5 Points

Round 2: Evidence based round (15-20 min)

  • In this round two questions would be asked to each team
  • Correct answer :10 Points
  • Wrong answer: -5 Points
  • No passing in this round

Round 3 : Connection point (20-25 min)

  • Each team would be given an array of different pictures you need to connect these different pictures.
  • Correct answer: 20 Points
  • Wrong answer : No Points
  • On passing, first on buzzer gets chance
  • Correct answer: 10 Points
  • Wrong answer : No Points

Round 4: Rapid fire (15 min)

  • Each team will be asked a set of ten questions each. They have to answer within 120 seconds.
  • Correct answer: 4 Points
  • Wrong answer : No Points
  • Tie breaker Round in case of a tie. QUIZ master’s decision to be final.
  • These rounds are subject to change.